LONA
LONA
NASDAQ · Pharmaceuticals

Leonabio Inc

$9.55
+0.73 (+8.28%)
As of May 9, 2:14 AM ET ·
Financial Highlights (FY 2025)
Revenue
9.05M
Net Income
1.50M
Gross Margin
56.9%
Profit Margin
16.6%
Rev Growth
-8.9%
D/E Ratio
0.33
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 56.9% 56.9% 56.9%
Operating Margin 20.3% 21.8% 20.7%
Profit Margin 16.6% 22.2% 21.9%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 9.05M 8.81M 7.55M
Gross Profit 5.15M 5.01M 4.29M
Operating Income 1.84M 1.92M 1.56M
Net Income 1.50M 1.95M 1.65M
Gross Margin 56.9% 56.9% 56.9%
Operating Margin 20.3% 21.8% 20.7%
Profit Margin 16.6% 22.2% 21.9%
Rev Growth -8.9% +8.5% +16.9%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 7.86M 7.59M 7.46M
Total Equity 24.10M 23.72M 25.10M
D/E Ratio 0.33 0.32 0.30
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 2.36M 2.47M 1.95M
Free Cash Flow 1.28M 1.29M 705.7K